Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proofofconcept study

Author：              

Publisher： Spandidos Publications

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.8, Iss.4, 2014-01, pp. : 1205-1208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study

By Aogi Kenjiro   Masuda Norikazu   Ohno Shinji   Oda Takashi   Iwata Hiroji   Kashiwaba Masahiro   Fujiwara Yasuhiro   Kamigaki Shunji   Ito Yoshinori   Ueno Takayuki   Takashima Shigemitsu  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 829-838

Springer Publishing Company

Access to resources Recommend Favorite

Patient‐Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo‐Controlled, Double‐Blind and 32‐Week Open‐Label Study

By  

The Oncologist, Vol. 23, Iss. 1, 2018-01 ,pp. : 16-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study

By Mross Klaus   Niemann Bernward   Massing Ulrich   Drevs Joachim   Unger Clemens   Bhamra Rupinder   Swenson Christine  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 514-524

Springer Publishing Company

Access to resources Recommend Favorite

A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer

By Tolcher Anthony   Appleman Leonard   Shapiro Geoffrey   Mita Alain   Cihon Frank   Mazzu Arthur   Sundaresan Pavur  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 751-764

Springer Publishing Company

Access to resources Recommend Favorite

An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)

By Coombes R. C.   Tat T.   Miller M. L.   Reise J. A.   Mansi J. L.   Hadjiminas D. J.   Shousha S.   Elsheikh S. E.   Lam E. W-F.   Horimoto Y.   El-Bahrawy M.   Aboagye E. O.   Contractor K. B.   Shaw J. A.   Walker R. A.   Marconell M. H.   Palmieri C.   Stebbing J.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 924-930

Oxford University Press

Access to resources Recommend Favorite